Gliclazide tablets 20mg “SAWAI” (YJ code: 3961007F2090, 20mg 1 tablet) are manufactured by Medisa New Drug and contain gliclazide. Gliclazide is a sulfonylurea medication used to treat type 2 diabetes by stimulating the pancreas to release more insulin and improving insulin sensitivity.
Gliclazide tablets 20mg “SAWAI”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
